Jul 31
|
Supernus Pharmaceuticals Completes Acquisition of Sage Therapeutics
|
Jul 30
|
Sage Therapeutics Announces Second Quarter 2025 Financial Results
|
Jul 30
|
Discover 3 Stocks Including Mid Penn Bancorp That May Be Trading Below Estimated Value
|
Jul 30
|
Why Supernus Pharmaceuticals (SUPN) Stock Is Up Today
|
Jul 30
|
3 Stocks Estimated To Be Trading At A Discount Of Up To 49.9%
|
Jul 30
|
Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Shares Could Be 50% Below Their Intrinsic Value Estimate
|
Jul 28
|
Supernus Pharmaceuticals Announces Expiration of Hart-Scott-Rodino Waiting Period for Sage Therapeutics, Inc. Tender Offer
|
Jul 25
|
Branded Pharmaceuticals Stocks Q1 Recap: Benchmarking Supernus Pharmaceuticals (NASDAQ:SUPN)
|
Jul 22
|
Supernus Pharmaceuticals to Announce Second Quarter 2025 Financial Results and Host Conference Call and Webcast on August 5, 2025
|
Jul 18
|
Why Supernus Pharmaceuticals (SUPN) Shares Are Falling Today
|
Jul 14
|
1 Stock Under $50 with Exciting Potential and 2 to Turn Down
|
Jul 10
|
2 Cash-Heavy Stocks to Own for Decades and 1 to Approach with Caution
|
Jul 1
|
Sector Update: Health Care Stocks Rise in Late Afternoon Trading
|
Jun 30
|
Sage to lay off most staff amid Supernus buyout
|
Jun 27
|
Supernus Pharmaceuticals’s Q1 Earnings Call: Our Top 5 Analyst Questions
|
Jun 13
|
3 Small-Cap Stocks Facing Headwinds
|
Jun 10
|
1 Cash-Producing Stock for Long-Term Investors and 2 to Keep Off Your Radar
|
May 21
|
3 Cash-Heavy Stocks in the Doghouse
|
Apr 24
|
3 Healthcare Stocks with Mounting Challenges
|
Apr 23
|
Supernus Pharmaceuticals to Announce First Quarter 2025 Financial Results and Host Conference Call and Webcast on May 6, 2025
|